ライフサイエンスコーパス: unencapsulated

1 at 5-10-fold lower concentrations than when unencapsulated.

2 cluded 144 (84.2%; 95% CI, 77.9%-89.3%) with unencapsulated, 11 (6.4%; 95% CI, 3.3%-11.2%) with serot

3 e vascular cell adhesion molecules, with the unencapsulated and truncated LOS strains being most pote

4 umoniae early lung infection with wild-type, unencapsulated, and para-amino benzoic acid auxotroph mu

5 primed or primed in vivo host lymphocytes to unencapsulated BAC cells in vitro.

6 r alveolar macrophage-dependent clearance of unencapsulated bacteria.

7 immune response relative to vaccination with unencapsulated BCG, including higher polysaccharide-spec

8 pharmacokinetics and efficacy compared with unencapsulated BPTES.

9 particular serotype by SAST were shown to be unencapsulated by PCR, and two isolates that were report

10 ate other applications, including removal of unencapsulated calcein from vesicles, remote loading and

11 n contrast, the control animal that received unencapsulated cells exhibited a complete loss of cell s

12 nd invasion of epithelial cells and that the unencapsulated cells within the population preferentiall

13 sults in two populations of encapsulated and unencapsulated cells.

14 were stimulated with encapsulated (COH1) or unencapsulated (COH1-13) whole type III GBS or with puri

15 were stimulated with encapsulated (COH1) or unencapsulated (COH1-13) whole type III GBS or with puri

16 sveratrol from dialysis bags compared to the unencapsulated compound.

17 ive encapsulated mutants compared with their unencapsulated counterparts (p < 0.01) when purified C1

18 Unencapsulated Deltapbp1a D39 mutants have smaller diame

19 ate, and laboratory strain R6, an avirulent, unencapsulated derivative of strain D39.

20 Furthermore, the performance of unencapsulated devices remains unchanged for over 150 da

21 g in 500 micro L, n = 6) or intravenous free unencapsulated doxorubicin (n = 7) was administered imme

22 d to calculate nanomedicine encapsulated and unencapsulated drug fractions.

23 lication in bread and milk was compared with unencapsulated (fish oil) and microencapsulated omega3 P

24 th daily i.v. injections of 50 micrograms of unencapsulated (free) glucose oxidase (P = 0.002 by log-

25 er (P<0.05) concentration than corresponding unencapsulated fruit by-product.

26 However, unencapsulated GBS were also invasive but only when cult

27 response was overcome by coimmunization with unencapsulated GBS-III.

28 ls treated with equivalent concentrations of unencapsulated gelonin or gelonin encapsulated alone in

29 imited CP-mediated killing by anti-fHbp, the unencapsulated group A mutant paradoxically was more res

30 ned factor(s) in a cytoplasmic extract of an unencapsulated group A streptococcal strain was binding

31 C3a generated by encapsulated and unencapsulated group B and C strains was similar, but CP

32 m were previously healthy and presented with unencapsulated H. influenzae bacteremia.

33 influenzae and 2.90 (95% CI, 2.11-3.89) for unencapsulated H. influenzae compared with the backgroun

34 The incidence rate of invasive unencapsulated H. influenzae disease was 17.2 (95% CI, 1

35 have an increased susceptibility to invasive unencapsulated H. influenzae disease.

36 Unencapsulated H. influenzae infection during the first

37 Unencapsulated H. influenzae infection during the second

38 aturally occurring bactericidal activity for unencapsulated H. influenzae is largely due to IgM antib

39 mplement-dependent bactericidal activity for unencapsulated H. influenzae.

40 ts were separately expressed in nontypeable (unencapsulated) H. influenzae, which did not bind FH, an

41 Unencapsulated Haemophilus influenzae frequently causes

42 Unencapsulated Haemophilus influenzae is the second most

43 In contrast to R36A, neither inactivated, unencapsulated, intact Neisseria meningitidis nor Strept

44 poly-l-lysine-cross-linked microcapsules and unencapsulated islets were included as controls.

45 encapsulation and was comparable to that of unencapsulated islets.

46 We engineered capsulated and unencapsulated isogenic mutant strains of groups A, B, C

47 ue sequence corresponds to a set of atypical unencapsulated isolates that may represent a distinct sp

48 spleen of mice infected with encapsulated or unencapsulated M. tuberculosis The combination of vaccin

49 e short physical half-life when delivered as unencapsulated material and in turn the short active hal

50 Similarly, primary immunization with unencapsulated MenC or GBS-III, to potentially prime CD4

51 Purified CPSs bound to unencapsulated meningococci, simulated findings with nat

52 nsory difference/similarity between control, unencapsulated, microencapsulated, and nanoliposomal ome

53 s > 1,000-fold more effective by weight than unencapsulated monomeric cHyp.

54 wever, these mutants were as sensitive as an unencapsulated mutant to killing by normal human serum.

55 at poorly encapsulated wild-type strains and unencapsulated mutants of group A Streptococcus entered

56 Rather, unencapsulated mutants remain agglutinated within lumena

57 Using a mouse model, we demonstrate that unencapsulated mutants remain capable of nasal colonizat

58 is time point C3 was barely activated by the unencapsulated mutants.

59 , C, W-135, and Y strains and their isogenic unencapsulated mutants.

60 uraminidases) that are not shared with other unencapsulated nasopharyngeal S. pneumoniae.

61 HrpA mutants in encapsulated and unencapsulated NMB strains demonstrated biofilm growth e

62 he use of NO/Ar-ELIP was 7-fold greater than unencapsulated NO.

63 n used in prior invasion studies, R6x, is an unencapsulated, nonpathogenic strain.

64 The ability of unencapsulated (nontypeable) Haemophilus influenzae (NTH

65 oxidation stability of nanoencapsulated and unencapsulated oil were evaluated during 28days of stora

66 owed higher stability against oxidation than unencapsulated oil.

67 le of controlling peroxide value better than unencapsulated OLE.

68 an in control mice after injection of either unencapsulated or encapsulated S. aureus, suggesting tha

69 er administration of various doses of either unencapsulated or encapsulated S. aureus; furthermore, m

70 nriched samples while, samples enriched with unencapsulated or microencapsulated omega3 PUFAs showed

71 endritic cells in vitro, and was superior to unencapsulated peptide or peptide encapsulated in an ana

72 Inhibition occurred with unencapsulated Pn, encapsulated Pn expressing different

73 A whole-cell killed unencapsulated pneumococcal vaccine given by the intrana

74 These studies suggest that killed whole-cell unencapsulated pneumococci given intranasally with an ad

75 were shown to contribute to the adherence of unencapsulated pneumococci, to human epithelial cells.

76 The instability of the unencapsulated prodrug in plasma allowed us to compare o

77 h serotype 2 pneumococcal strain D39 and its unencapsulated R6 derivative.

78 ated Streptococcus pneumoniae [including the unencapsulated S. pneumoniae, serotype 2 strain (R36A)]

79 of positive when incorporating new criteria (unencapsulated sheetlike enhancement) for DCE score of p

80 In mice with colitis, ultrasound delivery of unencapsulated siRNA against Tnf mRNA reduced protein le

81 signal resulting from both encapsulated and unencapsulated SRB molecules.

82 t challenge with lethal doses of toxinogenic unencapsulated Sterne 7702 spores and rabbits against ch

83 The unencapsulated strain CVD752 was quickly eliminated by t

84 s involved in the immune response, while the unencapsulated strain generally induced similar or great

85 cidal effect for Streptococcus mutans and an unencapsulated strain of Porphyromonas gingivalis follow

86 a college campus was caused by an atypical, unencapsulated strain of S. pneumoniae that was identica

87 ntact, inactivated Streptococcus pneumoniae (unencapsulated strain R36A) inhibits IgG responses to a

88 6B Streptococcus pneumoniae strain 603S and unencapsulated strain Rx1Delta lytA were modified to exp

89 In this study, transposon mutagenesis of an unencapsulated strain yielded an encapsulated mutant.

90 eliminated in developed countries; however, unencapsulated strains - nontypeable H. influenzae (NTHi

91 DeltamltG mutants in unencapsulated strains accumulate inactivation mutations

92 These findings suggest that the unencapsulated strains capable of causing conjunctivitis

93 tative sensor gene, csrS, in three different unencapsulated strains yielded encapsulated mutant strai

94 ers of a distinct cluster of closely related unencapsulated strains.

95 complement-mediated opsonophagocytosis than unencapsulated strains.

96 strains compared to that in the presence of unencapsulated strains.

97 P. gingivalis strains are more virulent than unencapsulated strains; however, the contribution of cap

98 he assembly with the rate of the reaction of unencapsulated substrates reveals rate accelerations of

99 Additionally, unencapsulated TFTs fabricated under ambient conditions

100 against P. aeruginosa PA01 was equivalent to unencapsulated tobramycin (minimum inhibitory concentrat

101 uorescence excitation spectra confirmed that unencapsulated TPT exhibits a red shift in its spectrum

102 Encapsulated and unencapsulated type 18 streptococci were equally opsoniz

103 USA300 isolates were unencapsulated, whereas 2 of 3 USA400 isolates produced

104 The unencapsulated white QD-LED has a long lifetime of 96 h